MOIRe is an annual open innovation research program for drug discovery initiated by Mochida Pharmaceutical Co.,Ltd, a large Japanese pharmaceutical company.

This year’s targets:
- Technologies to obtain ligands for the specific tissue delivery of oligonucleotide therapeutics
- Quantification of oligonucleotide concentrations in biological samples
- Monitoring the tissue and subcellular distribution of oligonucleotide therapeutics
- Other drug discovery technologies related to oligonucleotide therapeutics

• Eligible candidates: Researchers and research representatives affiliated with public research institutions, universities, etc. (also including researchers in university-originated venture companies) 
• Research expenses covered will be up to US$ 50,000 per project. 
• Application period: 1 June 2024, to 31 July 2024

Application form and more detailed information available online. 

Source: Mochida Pharmaceutical Co., Ltd